186 related articles for article (PubMed ID: 34970405)
1. Impact of pre-exposure and post-exposure prophylaxes prevention programme on HIV burden and services in a low-resource setting: a simulation modelling approach.
Adeoti AO; Demir E; Adeyemi S; Yakutcan U; Kengne AP; Kayode G; Aliyu A; Idika N; Isichei C
Pan Afr Med J; 2021; 40():163. PubMed ID: 34970405
[TBL] [Abstract][Full Text] [Related]
2. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.
Smith J; Bansi-Matharu L; Cambiano V; Dimitrov D; Bershteyn A; van de Vijver D; Kripke K; Revill P; Boily MC; Meyer-Rath G; Taramusi I; Lundgren JD; van Oosterhout JJ; Kuritzkes D; Schaefer R; Siedner MJ; Schapiro J; Delany-Moretlwe S; Landovitz RJ; Flexner C; Jordan M; Venter F; Radebe M; Ripin D; Jenkins S; Resar D; Amole C; Shahmanesh M; Gupta RK; Raizes E; Johnson C; Inzaule S; Shafer R; Warren M; Stansfield S; Paredes R; Phillips AN;
Lancet HIV; 2023 Apr; 10(4):e254-e265. PubMed ID: 36642087
[TBL] [Abstract][Full Text] [Related]
3. Uptake and outcomes of a novel community-based HIV post-exposure prophylaxis (PEP) programme in rural Kenya and Uganda.
Ayieko J; Petersen ML; Kabami J; Mwangwa F; Opel F; Nyabuti M; Charlebois ED; Peng J; Koss CA; Balzer LB; Chamie G; Bukusi EA; Kamya MR; Havlir DV
J Int AIDS Soc; 2021 Jun; 24(6):e25670. PubMed ID: 34152067
[TBL] [Abstract][Full Text] [Related]
4. Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.
Grangeiro A; Couto MT; Peres MF; Luiz O; Zucchi EM; de Castilho EA; Estevam DL; Alencar R; Wolffenbüttel K; Escuder MM; Calazans G; Ferraz D; Arruda É; Corrêa Mda G; Amaral FR; Santos JC; Alvarez VS; Kietzmann T
BMJ Open; 2015 Aug; 5(8):e009021. PubMed ID: 26307622
[TBL] [Abstract][Full Text] [Related]
5. Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review.
Elliott T; Sanders EJ; Doherty M; Ndung'u T; Cohen M; Patel P; Cairns G; Rutstein SE; Ananworanich J; Brown C; Fidler S
J Int AIDS Soc; 2019 Dec; 22(12):e25419. PubMed ID: 31850686
[TBL] [Abstract][Full Text] [Related]
6. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
[TBL] [Abstract][Full Text] [Related]
7. HIV Exposure Prophylaxis Delivery in a Low-barrier Substance Use Disorder Bridge Clinic during a Local HIV Outbreak at the Onset of the COVID-19 Pandemic.
Braun HM; Walter C; Farrell N; Biello KB; Taylor JL
J Addict Med; 2022 Nov-Dec 01; 16(6):678-683. PubMed ID: 36383918
[TBL] [Abstract][Full Text] [Related]
8. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
[TBL] [Abstract][Full Text] [Related]
9. HIV infections averted at PEPFAR-APIN clinics in Nigeria: a ten-year retrospective evaluation of the clinical outcomes of post-exposure prophylaxis services.
Isah A; Igboeli NU; Dim OF; Ekwuofu AA
Afr J AIDS Res; 2023 Apr; 22(1):46-53. PubMed ID: 36951407
[No Abstract] [Full Text] [Related]
10. Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.
Bershteyn A; Sharma M; Akullian AN; Peebles K; Sarkar S; Braithwaite RS; Mudimu E
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25527. PubMed ID: 32602669
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens.
Ramautarsing RA; Meksena R; Sungsing T; Chinbunchorn T; Sangprasert T; Fungfoosri O; Meekrua D; Sumalu S; Pasansai T; Bunainso W; Wongsri T; Mainoy N; Colby D; Avery M; Mills S; Vannakit R; Phanuphak P; Phanuphak N
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25540. PubMed ID: 32602660
[TBL] [Abstract][Full Text] [Related]
12. Immediate PrEP when accessing PEP: A service evaluation.
Cockbain B; Whitlock G;
HIV Med; 2022 Nov; 23(10):1108-1112. PubMed ID: 35352455
[TBL] [Abstract][Full Text] [Related]
13. The impact, cost and cost-effectiveness of oral pre-exposure prophylaxis in sub-Saharan Africa: a scoping review of modelling contributions and way forward.
Case KK; Gomez GB; Hallett TB
J Int AIDS Soc; 2019 Sep; 22(9):e25390. PubMed ID: 31538407
[TBL] [Abstract][Full Text] [Related]
14. UK guideline for the use of HIV post-exposure prophylaxis 2021.
Cresswell F; Asanati K; Bhagani S; Boffito M; Delpech V; Ellis J; Fox J; Furness L; Kingston M; Mansouri M; Samarawickrama A; Smithson K; Sparrowhawk A; Rafferty P; Roper T; Waters L; Rodger A; Gupta N
HIV Med; 2022 May; 23(5):494-545. PubMed ID: 35166004
[TBL] [Abstract][Full Text] [Related]
15. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
Jain S; Krakower DS; Mayer KH
Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
[TBL] [Abstract][Full Text] [Related]
16. A community-based dynamic choice model for HIV prevention improves PrEP and PEP coverage in rural Uganda and Kenya: a cluster randomized trial.
Kakande ER; Ayieko J; Sunday H; Biira E; Nyabuti M; Agengo G; Kabami J; Aoko C; Atuhaire HN; Sang N; Owaranganise A; Litunya J; Mugoma EW; Chamie G; Peng J; Schrom J; Bacon MC; Kamya MR; Havlir DV; Petersen ML; Balzer LB;
J Int AIDS Soc; 2023 Dec; 26(12):e26195. PubMed ID: 38054535
[TBL] [Abstract][Full Text] [Related]
17. Community perspectives on addressing and responding to HIV-testing, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) among African, Caribbean and Black (ACB) people in Ontario, Canada.
Etowa J; Tharao W; Mbuagbaw L; Baidoobonso S; Hyman I; Obiorah S; Aden M; Etowa EB; Gebremeskel A; Kihembo M; Nelson L; Husbands W
BMC Public Health; 2022 May; 22(1):913. PubMed ID: 35525946
[TBL] [Abstract][Full Text] [Related]
18. Addressing the Need for a Preexposure Prophylaxis Monitoring and Evaluation Implementation Guide: Experience From Zambia.
Lavoie MC; Blanco N; Mwango LK; Nichols BE; Whittington A; Lindsay B; Adebayo O; Mujansi M; Tembo K; Hachaambwa L; Mumba D; Musonda B; Claassen CW
Glob Health Sci Pract; 2023 Apr; 11(2):. PubMed ID: 37116937
[TBL] [Abstract][Full Text] [Related]
19. Overlapping HIV prevention strategies; case report of pre-exposure and postexposure prophylaxes used for a single risk event between two men.
Smith DE; Gardiner J; Oliver R; Fagan D
Sex Transm Infect; 2017 Jun; 93(4):238-239. PubMed ID: 25795661
[TBL] [Abstract][Full Text] [Related]
20. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
